PhaseBio Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all PhaseBio Pharmaceuticals patents 14 in total
| Status | Patent |
|---|---|
Grant | Utility: Methods and compositions for treating muscle disease and disorders Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: METALLOENZYME INHIBITOR COMPOUNDS Filling date: 6 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: METHODS OF REVERSING TICAGRELOR ACTIVITY Filling date: 6 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: METALLOENZYME INHIBITOR COMPOUNDS Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Metalloenzyme inhibitor compounds Filling date: 6 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Methods and compositions for treating cystic fibrosis Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Metalloenzyme inhibitor compounds Filling date: 6 Sep 2025 Issue date: 22 Jun 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS Filling date: 6 Sep 2025 Issue date: 11 Mar 2021 |
Grant | Utility: Use of modified vasoactive intestinal peptides in the treatment of hypertension Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Application | Utility: METALLOENZYME INHIBITOR COMPOUNDS Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: ELP fusion proteins for controlled and sustained release Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Methods and compositions for treating muscle disease and disorders Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Showing 1 to 14 of 14 patents.